[1] |
Murawski N, Zwick C, PfreundschuhM. Unresolved issues in diffuse large B-cell lymphomas[J].Expert Rev Anticancer Ther, 20 10, 10(3):387-402.
|
[2] |
Tang YH, Zhong MZ, Liu W, et al. Clone of the Survivin promoter and its specific transcriptional activity in human lymphoma cells[J]. Bai Xue Bing·Lin Ba Liu, 2010, 19(2): 84-7. [唐友红,钟 美佐,刘巍,等. 人类生存蛋白启动子的克隆及其在淋巴瘤细胞 中的转录活性研究[J].白血病·淋巴瘤, 2010, 19(2): 84-7.]
|
[3] |
Ray S, Paulmurugan R, Patel MR, et al.Noninvasive imaging of therapeutic gene expression using a bidirectional transcriptional amplification strategy[J]. Mol Ther, 2008, 16(11):1848-56.
|
[4] |
Donofrio G, Cavirani S, Vanderplasschen A, et al. Recombinant bovine herpesvirus 4 (BoHV-4) expressing glycoprotein D of BoHV-1 is immunogenic and elicits serum-neutralizing antibodies against BoHV-1 in a rabbit model[J]. Clin Vaccine Immunol, 20 06, 13(11):1246-54.
|
[5] |
Zhang L, Adams JY, Billick E, et al. Molecular engineering of a two-step transcription amplification(TSTA) system for transgene delivery in prostate cancer[J]. Mol Ther, 2002, 5(3):223-32.
|
[6] |
Iyer M, Wu L, Carey M,et al. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters[J]. Proc Natl Acad Sci U S A, 2001, 98(25):14595-600.
|
[7] |
Song Y, Shen K, He CX. Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma [J]. Zhonghua Fu Chan Ke Za Zhi, 20 07, 42(9):617-22. [宋悦,沈铿,何春霞.人端粒酶逆转录酶 启动子-二步转录增强系统调控下的活性半胱氨酸天冬氨酸蛋 白酶3的构建及其对卵巢上皮性癌的治疗作用[J]. 中华妇产科 杂志, 2007, 42(9):617-22.]
|
[8] |
Sims K, Ahmed Z, Gonzalez AM, et al. Targeting adenoviral transgene expression to neurons[J]. Mol Cell Neurosci, 2008, 39 (3):411-7.
|
[9] |
Mariati, Ho SC, Yap MG, et al. Evaluating post-transcriptional regulatory elements for enhancing transient gene expression levels in CHO K1 and HEK293 cells[J]. Protein Expr Purif, 2010, 69 (1):9-15.
|
[10] |
Xie X, Xia W, Li Z, et al. Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models[J]. Cancer Cell, 20 07, 12(1):52-65.
|
[11] |
Sher YP, Liu SJ, Chang CM,et al. Cancer-targeted BikDD gene therapy elicits protective antitumor immunity against lung cancer[J]. Mol Cancer Ther, 2011, 10(4): 637-47.
|
[12] |
Xie X, Hsu JL, Choi MG, et al. A novel hTERT promoter-driven E1A therapeutic for ovarian cancer[J]. Mol Cancer Ther, 2009, 8( 8):2375-82.
|